|1.||Kunihiro, M: 1 article (08/2000)|
|2.||Haruma, K: 1 article (08/2000)|
|3.||Nishiyama, M: 1 article (08/2000)|
|4.||Yoshihara, M: 1 article (08/2000)|
|5.||Kitadai, Y: 1 article (08/2000)|
|6.||Tanaka, S: 1 article (08/2000)|
|7.||Sumii, K: 1 article (08/2000)|
|8.||Kajiyama, G: 1 article (08/2000)|
01/01/1992 - "In extracts of various cancer cells, the high deoxycytidine kinase activity was competitively inhibited by difluorodeoxycytidine (DFDC), with Ki = 7 to 30 microM. "
08/01/2000 - "Furthermore, these tumors also showed a higher Ki-7 labeling index, and a stronger epidermal growth factor receptor and transforming growth factor alpha mRNA expression than primary and control tumors in the colo201 implanted groups. "
|2.||HTLV-I Infections (HTLV-I Infection)
|4.||Hepatocellular Carcinoma (Hepatoma)
|2.||Transforming Growth Factor alpha (TGF-alpha)
|3.||Factor Xa (Coagulation Factor Xa)
|4.||Messenger RNA (mRNA)
|5.||Epidermal Growth Factor Receptor (EGF Receptor)